
Biotechnology
TopicHeard in 6 episodes across 6 shows since Nov 2026
Biotechnology is a multidisciplinary field combining biology, natural sciences, and engineering to use living organisms, cells, and biological molecules to develop products and services. It includes applications in medicine and pharmaceuticals, agriculture, food production, environmental science, and industrial processes; in the podcast context, “biotech” most often refers to biotechnology companies, scientific development pipelines, and their investment prospects, including the effects of AI on research and investing.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Biotechnology per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Nov 10 | 0.01‰ | 1 |
| Nov 12 | 0.02‰ | 2 |
| Nov 15 | 0.05‰ | 3 |
| Nov 17 | 0.07‰ | 4 |
| Nov 21 | 0.09‰ | 4 |
Email alert
Email me when Biotechnology comes up on a podcast
One email a week at most, with the new episodes that mention Biotechnology. Free, no account needed, unsubscribe in one click.
What experts have said about Biotechnology
6 statements · 2 positive · 4 negative
European investors may need U.S. crossover or U.S.-based investors for NASDAQ listings.
“if they ever want to go public on NASDAQ, you know, a premise that they have to do. They're not going to be able to do that if they don't have U.S. crossovers or U.S.-based investors.”
Open the episode · Ep. 399 - Key themes from Jefferies. Plus: U.K. regulatory innovationListen at 20:07
Biotechs should announce financings immediately after positive data to capture value.
“when you have good data, you should announce a financing right away because if you let the market sit, given the broader... market, you may not be able to capture value”
Open the episode · Episode 204 - November 20, 2026Listen at 49:46
Biotech markets do not properly incentivize building large independent businesses.
“I actually don't think the incentive structures and markets are set up the right way to go do that.”
Open the episode · Anthropic IPO, GTA 6 Launch, Strauss Zelnick Joins | Hemant TanejaListen at 1:24:30
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
6 episodes featuring Biotechnology, newest first
- Nov 21, 2026
China builds an AI stack beyond NVIDIAOdd LotsNov 21, 2026 - Nov 17, 2026
Stansberry sees an AI bust before the next productivity boomThoughtful Money with Adam TaggartNov 17, 2026 - Nov 15, 2026
Ross Haber blends O’Neil discipline with Weinstein timingThe TraderLion PodcastNov 15, 2026 - Nov 15, 2026
Meb Faber builds a portfolio for getting rich and staying richExcess Returns Nov 15, 2026 - Nov 12, 2026
Biotech’s uncertainty creates disciplined investment opportunitiesThe Acquirers PodcastNov 12, 2026 - Nov 10, 2026
Hot inflation tests market leadership and fresh stock setupsStock Market Today With IBDNov 10, 2026